- Report
- June 2023
- 143 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- April 2024
- 194 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- February 2024
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Report
- October 2023
- 181 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- May 2023
- 177 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- January 2024
- 302 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- September 2023
- 129 Pages
United States
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2023
- 30 Pages
United States
From €825EUR$916USD£732GBP
- Report
- May 2018
- 185 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- August 2021
- 200 Pages
Global
From €2316EUR$2,400USD£1,987GBP
- Report
- March 2023
- 130 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- April 2023
- 168 Pages
Global
From €1892EUR$1,960USD£1,623GBP
€2365EUR$2,450USD£2,028GBP
- Report
- March 2022
- 300 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2022
- 115 Pages
Global
From €2403EUR$2,490USD£2,062GBP
- Report
- January 2021
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- April 2021
- 148 Pages
Europe
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- April 2021
- 150 Pages
Asia Pacific
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- April 2021
- 141 Pages
Middle East, Africa
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more